Skip to content

The effect of grape seed on sperm parameters of infertile men

Investigating the effect of Grape Seed on sperm parameters and sperm DNA fragmentation rate in infertile men

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240528061937N1
Enrollment
52
Registered
2024-08-28
Start date
2024-08-07
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Male infertility. Male infertility

Interventions

Intervention group: taking grape seed extract tablets for 2 months with a daily dose of two 250 mg tablets. The name of the selected drug is Quetrol Resveratrol from Raha Pharmaceutical Company in a p

Sponsors

Arak University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: Sperm parameters are abnormal Not taking other antioxidant drugs by infertile men. the SDFA test (Sperm DNA Fragmentation Assay) shows the presence of fragmented DNA in more than 15% of ejaculated sperm. The age of the patients should be between 20 and 45

Exclusion criteria

Exclusion criteria: Patients with varicocele inflammation of the genital tract or infection men with a history of smoking, alcohol and drug addiction are excluded from the study. Genital tract infection

Design outcomes

Primary

MeasureTime frame
Improving the state of sperm parameters (concentration , morphology and motility). Timepoint: At the beginning of the study (before the start of the intervention) and 2 months after the start of taking grapeseed. Method of measurement: Light microscopy and Diff-quick staining.;Reducing the amount of DNA fragmentation. Timepoint: At the beginning of the study (before the start of the intervention) and 2 months after the start of taking grapeseed. Method of measurement: Using the SDFA (Sperm DNA Fragmentation Assay) kit.

Secondary

MeasureTime frame
Side effects. Timepoint: During the intervention. Method of measurement: Follow up.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Somayeh Shabib

Arak University of Medical Sciences

shabib333@gmail.com+98 913 321 0542

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026